United States of America v. Crescendo Bioscience, Inc.
Opinion
trial_court Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 UNITED STATES OF AMERICA, et al., Case No. 16-cv-02043-TSH
8 Plaintiffs,
ORDER RE: MOTION TO DISMISS
9 v. Re: Dkt. No. 49 10 CRESCENDO BIOSCIENCE, INC., et al., 11 Defendants.
12 13 I. INTRODUCTION 14 Plaintiff-Realtor STF, LLC brings this qui tam action on behalf of the United States and 15 the State of California against Defendants Crescendo Bioscience, Inc. and Myriad Genetics, Inc., 16 under the Federal False Claims Act, California False Claims Act, and California Insurance Frauds 17 Prevention Act. Before the Court is Defendants’ Motion to Dismiss STF’s First Amended 18 Complaint (“MTD”), ECF No. 49, which seeks dismissal of STF’s claims pursuant to Federal 19 Rules of Civil Procedure 9(b) and 12(b)(6). The Court finds this matter suitable for disposition 20 without oral argument and VACATES the May 28, 2020 hearing. See Civ. L.R. 7-1(b). Having 21 considered the parties’ positions, relevant legal authority, and the record in this case, the Court 22 DENIES…